Sentinel lymphadenectomy in breast cancer: Identification of sentinel lymph node and detection of metastases

Breast Cancer Research and Treatment

Volumn 53, Issue 2, 1999, Pages 97-104

  Noguchi, Masakuni ^a   Tsugawa, Koichiro ^a   Bando, Etsuro ^a   Kawahara, Futoshi ^a   Miwa, Koichi ^a   Yokoyama, Kunihiko ^a   Nakajima, Ken Ichi ^a   Tonami, Norihisa ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Axillary dissection; Breast cancer; Sentinel lymphadenectomy

Indexed keywords

DYE; EOSIN; HEMATOXYLIN;

ARTICLE; BREAST CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING;

EID: 0032961678     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006118827167     Document Type: Article

References (50)

1. 1. Gulec SA, Moffat FL, Carroll RG: The expanding clinical role of intraoperative gamma probes. Nucl Med Annual (accepted for publication)
2. 2. Cabanas R: An approach for the treatment of penile carcinoma. Cancer 39: 456-466, 1977
3. 3. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127: 392-399, 1992
4. 4. Alex JC, Weaver DL, Fairbank JT, et al.: Gamma probe guided lymph node localization in malignant melanoma. Surg Oncol 2: 303-308, 1993
5. 5. Krag DN, Meijer S, Weaver DL, et al.: Minimal assess surgery for staging of malignant melanoma. Arch Surg 130: 654-658, 1995
6. 6. Pijpers R, Collet GJ, Meijer S, Hoekstra OS: The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 22: 1238-1241, 1995
7. 7. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenopathy for breast cancer. Ann Surg 220: 391-401, 1994
8. 8. Giuliano AE: Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol 62(2): 75-77, 1996
9. 9. Albertini JA, Lyman GH, Cox C, et al.: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276: 1818-1822, 1996
10. 10. Veronesi U, Paganelli G, Galimberti V, et al.: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349: 1864-1867, 1997
11. 11. Krag DN, Weaver DL, Alex C, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2: 335-340, 1993
12. 12. Pijpers R, Meijer S, Hoekstra OS, et al.: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38: 366-368, 1997
13. 13. Giuliano AE, Dale PS, Turner RB, et al.: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222: 394-401, 1995
14. 14. Giuliano AE: Sentinel lymphadenectomy: A new axillary staging procedure for primary breast carcinoma. Breast Dis 7: 16-17, 1996
15. 15. Turner RR, Ollila DW, Krasne DL, Giuliano AE: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226: 271-278, 1997
16. 16. Noguchi M, Kawahara F, Tsugawa K, et al.: Sentinel lymphadenectomy in breast cancer: Alternative to routine axillary dissection. Breast Cancer 5: 1-7, 1998
17. 17. Alazraki N: Lymphoscintigraphy and the intraoperative gamma probe. J Nucl Med 36: 1780-1783, 1995
18. 18. Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15: 2345-2350, 1997
19. 19. Strand SE, Persson BRR: Quantitative lymphoscintigraphy: basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 20: 1038-1046, 1979
20. 20. Frier M, Griffiths P, Ramsey A: The physical and chemical characteristics of sulphur colloids. Eur J Nucl Med 6: 255-260, 1981
21. 21. Alex CJ, Krag DN: The gamma-probe-guided resection of radiolabelled primary lymph nodes. Surg Oncol North Am 5: 33-41, 1996
22. 22. Uren RF, Howman-Giles RB, Thompson JF, et al.: Mammary lymphoscintigraphy in breast cancer. J Nucl Med 36: 1775-1780, 1995
23. 23. Shons A, Joseph E, Cox CE, et al.: Predictors of sentinel lymph node metastases in the lymphatic mapping of breast cancer patients. Breast Cancer Res Treat 46 (1): 24, 1997 (abstract).
24. 24. Weissleder R, Elizondo G, Wittenberg J, et al.: Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175: 494-498, 1990
25. 25. McLachlan SJ, Morris MR, Lucas MA, et al.: Phase I clinical evaluation of a new iron oxide MR contrast agent. J Mag Reson Imaging 4: 301-307, 1994
26. 26. O'Hagan DT, Chirsty NM, Davis SS: Particulates and lymphatic drug delivery. In: Charman WN, Stella WN, Valentino J (eds) Lymphatic Transport of Drugs. Boca Raton FL, CRC Press, 1992, pp 279-315
27. 27. Noguchi M: Comment on "Improved axillary staging of breast cancer with sentinel lymphadenectomy". Ann Surg 225: 126-127, 1997
28. 28. Veronesi U, Cascinelli N, Greco M, et al.: Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 20: 702-707, 1985
29. 29. Noguchi M, Ohta N, Koyasaki N, et al.: Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Cancer 68: 1918-1925, 1991
30. 30. Noguchi M, Taniya T, Tsugawa K, Miwa K: The role of internal mammary lymph node metastases in the management of breast cancer. Breast Cancer 5: 117-125, 1998
31. 31. Bland KI: Enhancing the accuracy for predictors of axillary nodal metastasis in T1 carcinoma of the breast: role of selective biopsy with lymphatic mapping. J Am Coll Surg 183: 262-264, 1996
32. 32. Chilosis M, Lestani M, Pedron S, et al.: A rapid immunostaining method for frozen section. Biotechnic Histochem 69: 235-239, 1994
33. 33. Blaustein PA, Silverberg SG: Rapid cytologic examination of surgical specimens. Pathol Annu 12(2): 251-278, 1977
34. 34. Hadjiminas DJ, Burke M: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 81: 1615-1616, 1994
35. 35. Fisher CJ, Boyle S, Burke M, Price A: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 80: 457-458, 1993
36. 36. Noguchi S, Aihara T, Nakamori S, et al.: The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 74: 1595-1600, 1994
37. 37. Noguchi S, Aihara T, Motomura K, et al.: Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Am J Pathol 2: 649-656, 1996
38. 38. Schoenfeld A, Lugmani Y, Smith D, et al.: Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54: 2986-2990, 1994
39. 39. International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335: 1565-1568, 1990
40. 40. Trojani M, de Mascarel I, Bonichon F, et al.: Micrometastases to axillary lymph nodes from carcinoma of breast: Detection by immunohistochemistry and prognostic significance. Br J Cancer 55: 303-306, 1987
41. 41. Sedmak DD, Meineke TA, Knechtges DS, et al.: Prognostic significance of cytokeratin-positive breast cancer metastases. Med Pathol 2: 516-520, 1989
42. 42. Chen Z-L, Wen D-R, Coulson WF, et al.: Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology. Dis Markers 9: 239-248, 1991
43. 43. de Mascarel I, Bonichon F, Coindre JM, et al.: Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: Reevaluation with longer follow-up. Br J Cancer 66: 523-527, 1992
44. 44. Hainsworth PJ, Tjandra JJ, Stillwel RG, et al.: Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 80: 459-463, 1993
45. 45. Rosen PP, Oberman HA: Tumors of the mammary gland. Washington, DC: Armed Forces Institute of Pathology, 355-365, 1992
46. 46. Edlow DW, Carter D: Heterotopic epithelium in axillary lymph nodes: report of a case and review of the literature. Am J Clin Pathol 59: 666-673, 1973
47. 47. Holdsworth PJ, Hopkinson JM, Leveson SH: Benign axillary epithelial lymph node inclusion - a histological pitfall. Histopathology 13: 226-228, 1988
48. 48. Doglioni C, Dell'Orto P, Zanetti G, et al.: Cytokeratinimmunoreactive cells of human lymph nodes and spleen in normal and pathological conditions. An immunocytochemical study. Virchows Arch A Pathol Anat Histopathol 416: 479-490, 1990
49. 49. Noguchi M, Katev N, Miyazaki I: Diagnosis of axillary lymph node metastasis in patients with breast cancer. Breast Cancer Res Treat 40: 283-293, 1996
50. 50. National Cancer Institute: PDQ Clinical Trials (Internet)